Soyasaponin Ba

Overview

Soyasaponin Ba is a soyasaponin that can be isolated from Phaseolus vulgaris , acts as an aldose reductase inhibitor (ARI). Soyasaponin Ba activates Akt/GSK3β/β-catenin signaling pathway, reduces lipid accumulation, lowers ROS generation, improves mitochondrial membrane potential, ATP levels, and morphology, and inhibits apoptosis . Soyasaponin Ba can be used for the research of lipid accumulation and secondary diabetic complications.

Application

Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > PI3K/Akt/mTOR | Products > Signaling Pathways > Stem Cell/Wnt | Products > Signaling Pathways > Immunology/Inflammation | Products > Signaling Pathways > NF-κB | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > GSK-3 | Products > Signaling Pathways > β-catenin | Products > Signaling Pathways > Reactive Oxygen Species (ROS) | Products > Signaling Pathways > Mitochondrial Metabolism | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > c-Myc | Products > Signaling Pathways > Aldose Reductase | Products > Signaling Pathways > Akt

Product Information

• Catalog No.: HY-N0309
• CAS No.: 114590-20-4
• Molecular Formula: C48H78O19
• Molecular Weight: 959.12
• Purity: 99.47%
• Storage: 4°C, protect from light * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
• Availability: In-stock

Source

Original product source